M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.377 PLN -2.08% Market Closed
Market Cap: 25.6m PLN
Have any thoughts about
Medicofarma Biotech SA?
Write Note

Medicofarma Biotech SA
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medicofarma Biotech SA
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
M
Medicofarma Biotech SA
WSE:MDB
Total Current Liabilities
zł3.3m
CAGR 3-Years
74%
CAGR 5-Years
40%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Total Current Liabilities
zł2.5m
CAGR 3-Years
-38%
CAGR 5-Years
-6%
CAGR 10-Years
-3%
R
Ryvu Therapeutics SA
WSE:RVU
Total Current Liabilities
zł97.5m
CAGR 3-Years
60%
CAGR 5-Years
37%
CAGR 10-Years
23%
S
Selvita SA
WSE:SLV
Total Current Liabilities
zł106.8m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medicofarma Biotech SA
Glance View

Market Cap
25.6m PLN
Industry
Life Sciences Tools & Services

Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2008-11-27. The company is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.

MDB Intrinsic Value
0.096 PLN
Overvaluation 75%
Intrinsic Value
Price
M

See Also

What is Medicofarma Biotech SA's Total Current Liabilities?
Total Current Liabilities
3.3m PLN

Based on the financial report for Dec 31, 2023, Medicofarma Biotech SA's Total Current Liabilities amounts to 3.3m PLN.

What is Medicofarma Biotech SA's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
40%

Over the last year, the Total Current Liabilities growth was 0%. The average annual Total Current Liabilities growth rates for Medicofarma Biotech SA have been 74% over the past three years , 40% over the past five years .

Back to Top